Novocure Non Current Liabilities Other from 2010 to 2025

NVCR Stock  USD 18.86  0.11  0.58%   
Novocure Non Current Liabilities Other yearly trend continues to be relatively stable with very little volatility. Non Current Liabilities Other is likely to drop to about 15.4 K. During the period from 2010 to 2025, Novocure Non Current Liabilities Other destribution of quarterly values had range of 31.9 M from its regression line and mean deviation of  3,563,253. View All Fundamentals
 
Non Current Liabilities Other  
First Reported
2015-09-30
Previous Quarter
18 K
Current Value
18 K
Quarterly Volatility
9.3 M
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.2 M, Interest Expense of 18.2 M or Selling General Administrative of 97.7 M, as well as many indicators such as Price To Sales Ratio of 5.04, Dividend Yield of 0.0 or PTB Ratio of 13.33. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Non Current Liabilities Other Growth Pattern

Below is the plot of the Non Current Liabilities Other of Novocure over the last few years. It is Novocure's Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Other10 Years Trend
Very volatile
   Non Current Liabilities Other   
       Timeline  

Novocure Non Current Liabilities Other Regression Statistics

Arithmetic Mean3,433,974
Geometric Mean573,597
Coefficient Of Variation225.59
Mean Deviation3,563,253
Median3,127,000
Standard Deviation7,746,811
Sample Variance60T
Range31.9M
R-Value(0.03)
Mean Square Error64.2T
R-Squared0.0009
Significance0.91
Slope(49,701)
Total Sum of Squares900.2T

Novocure Non Current Liabilities Other History

202515.4 K
202416.2 K
202318 K
2022148 K
2021166 K
202031.9 M
2019182 K

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Other16.2 K15.4 K

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.